首页> 美国卫生研究院文献>ACS AuthorChoice >Impact of Multiple Negative Charges on Blood Clearanceand Biodistribution Characteristics of 99mTc-Labeled DimericCyclic RGD Peptides
【2h】

Impact of Multiple Negative Charges on Blood Clearanceand Biodistribution Characteristics of 99mTc-Labeled DimericCyclic RGD Peptides

机译:多种负电荷对血液清除的影响99mTc标记的二聚体的合成及生物分布特征环状RGD肽

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study sought to evaluate the impact of multiple negative charges on blood clearance kinetics and biodistribution properties of 99mTc-labeled RGD peptide dimers. Bioconjugates HYNIC-P6G-RGD2 and HYNIC-P6D-RGD2 were prepared by reacting P6G-RGD2 and P6D-RGD2, respectively, with excess HYNIC-OSu in the presence of diisopropylethylamine. Their IC50 values were determined to be 31 ± 5 and 41 ± 6 nM, respectively, against 125I-echistatin bound to U87MG glioma cells in a whole-cell displacement assay. Complexes [99mTc(HYNIC-P6G-RGD2)(tricine)(TPPTS)] (99mTc-P6G-RGD2) and [99mTc(HYNIC-P6D-RGD2)(tricine)(TPPTS)] (99mTc-P6D-RGD2) were prepared in high radiochemical purity (RCP > 95%) and specific activity (37–110 GBq/μmol). They were evaluated in athymic nude mice bearing U87MG glioma xenografts for their biodistribution. The most significant difference between 99mTc-P6D-RGD2 and 99mTc-P6G-RGD2 was their blood radioactivity levels and tumor uptake. The initial blood radioactivity level for 99mTc-P6D-RGD2 (4.71 ± 1.00%ID/g) was ∼5× higher than that of 99mTc-P6G-RGD2 (0.88 ± 0.05%ID/g), but this difference disappeared at 60 min p.i. 99mTc-P6D-RGD2 had much lower tumor uptake (2.20–3.11%ID/g) than 99mTc-P6G-RGD2 (7.82–9.27%ID/g) over a 2 h period. Since HYNIC-P6D-RGD2 and HYNIC-P6G-RGD2 shared a similar integrin αvβ3 binding affinity (41 ± 6 nM versus 31 ± 5 nM), the difference in their blood activity and tumor uptake is most likely related tothe nine negative charges and high protein binding of 99mTc-P6D-RGD2. Despite its low uptake in U87MG tumors, thetumor uptake of 99mTc-P6D-RGD2 was integrinαvβ3-specific. SPECT/CT studieswere performed using 99mTc-P6G-RGD2 in athymicnude mice bearing U87MG glioma and MDA-MB-231 breast cancer xenografts.The SPECT/CT data demonstrated the tumor-targeting capability of 99mTc-P6G-RGD2, and its tumor uptake depends onthe integrin αvβ3 expression levelson tumor cells and neovasculature. It was concluded that the multiplenegative charges have a significant impact on the blood clearancekinetics and tumor uptake of 99mTc-labeled dimeric cyclicRGD peptides.
机译:本研究旨在评估多个负电荷对 99m Tc标记的RGD肽二聚体血液清除动力学和生物分布特性的影响。生物共轭物HYNIC-P6G-RGD2和HYNIC-P6D-RGD2是通过使P6G-RGD2和P6D-RGD2与过量的HYNIC-OSu在二异丙基乙胺存在下反应制备的。在全细胞置换试验中,针对结合到U87MG胶质瘤细胞的 125 I-echistatin,它们的IC50值分别确定为31±5和41±6 nM。配合物[ 99m Tc(HYNIC-P6G-RGD2)(三氢)(TPPTS)]( 99m Tc-P6G-RGD2)和[ 99m 制备的Tc(HYNIC-P6D-RGD2)(三氢)(TPPTS)]( 99m Tc-P6D-RGD2)以高放射化学纯度(RCP> 95%)和比活(37–110 GBq)制备/μmol)。在携带U87MG胶质瘤异种移植物的无胸腺裸鼠中评估了它们的生物分布。 99m Tc-P6D-RGD2和 99m Tc-P6G-RGD2之间最大的区别是血液放射性水平和肿瘤吸收。 99m Tc-P6D-RGD2的初始血液放射性水平(4.71±1.00%ID / g)比 99m Tc-P6G-RGD2的初始血液放射性水平高约5倍( 0.88±0.05%ID / g),但差异在pi 60分钟时消失 99m Tc-P6D-RGD2的肿瘤摄取(2.20–3.11%ID / g)比 99m Tc-P6G-RGD2(7.82–9.27%ID / g)低得多在2小时内。由于HYNIC-P6D-RGD2和HYNIC-P6G-RGD 2 共享相似的整联蛋白α v β 3 结合亲和力(41±6 nM vs 31±5 nM),其血液活性和肿瘤吸收的差异很可能与 99m Tc-P6D-RGD 2 的九个负电荷和高蛋白结合。尽管其对U87MG肿瘤的摄取较低,但是整联蛋白 99m Tc-P6D-RGD 2 的肿瘤摄取α v β 3 特定。 SPECT / CT研究在无胸腺中使用 99m Tc-P6G-RGD 2 进行携带U87MG神经胶质瘤和MDA-MB-231乳腺癌异种移植物的裸鼠。SPECT / CT数据显示 99m Tc-P6G-RGD 2 的肿瘤靶向能力,其肿瘤吸收取决于整联蛋白α v β 3 的表达水平在肿瘤细胞和新脉管系统上。结论是,倍数负电荷会对血液清除产生重大影响99m Tc标记的二聚环的动力学和肿瘤吸收RGD肽。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号